Showing 881 - 900 results of 1,115 for search '"heart failure"', query time: 0.06s Refine Results
  1. 881

    An Intriguing Case of Multisystem Inflammatory Syndrome in an Adult Patient with Remote Infection with COVID-19 and Acute Chlamydia by Madhuri Chandnani, William A. Charini, Anil Jha, Chetan Dodhia, Eduardo Haddad

    Published 2021-01-01
    “…A 27-year-old male patient presented with acute epididymitis secondary to acute Chlamydia infection that progressed to multisystem inflammatory failure with respiratory failure requiring endotracheal intubation and mechanical ventilation, cardiogenic shock with heart failure, and gastrointestinal and renal dysfunction. …”
    Get full text
    Article
  2. 882
  3. 883

    Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy? by Alyaa A. Kotby, Manal M. Abdel Aziz, Waleed M. El Guindy, Amira N. Moneer

    Published 2013-01-01
    “…Increased serum TN-C can be used as a marker of inflammation in DCM and is associated with the severity of heart failure and LV dysfunction as detected by STE.…”
    Get full text
    Article
  4. 884

    Maternal Cardiac Function after Normal Delivery, Preeclampsia, and Eclampsia: A Prospective Study by Elena Timokhina, Tatiana Kuzmina, Alexander Strizhakov, Elena Pitskhelauri, Irina Ignatko, Vera Belousova

    Published 2019-01-01
    “…The revealed decreasing of contractile function of the heart is a sign of asymptomatic heart failure. Conclusions. The hemodynamics of the puerperas after PE and E is characterized by impaired contractility of the myocardium and an increase in the indices of peripheral resistance. …”
    Get full text
    Article
  5. 885

    Lipotoxicity and metabolic disorders at obesity by V. T. Ivashkin, M. V. Mayevskaya

    Published 2010-02-01
    “…The most serious metabolic disorders related to obesity, include non-alcoholic fatty liver disease (NAFLD), diabetes mellitus, systemic hypertension with gradual development of heart failure, dyslipidemia, night apnea, etc. Recently scientists are more involved into the concept of limitation of fat tissue capacity to increase its volume as a factor associating obesity to metabolic syndrome and NAFLD. …”
    Get full text
    Article
  6. 886

    Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities by Ignacio M. Seropian, Germán E. González, Sebastián M. Maller, Daniel H. Berrocal, Antonio Abbate, Gabriel A. Rabinovich

    Published 2018-01-01
    “…Here, we discuss the emerging roles of Gal-1 in cardiovascular diseases including acute myocardial infarction, heart failure, Chagas cardiomyopathy, pulmonary hypertension, and ischemic stroke, highlighting underlying anti-inflammatory mechanisms and therapeutic opportunities. …”
    Get full text
    Article
  7. 887

    The Association between the Pulmonary Arterial Obstruction Index and Atrial Size in Patients with Acute Pulmonary Embolism by Taraneh Faghihi Langroudi, Maryam Sheikh, Mohammadreza Naderian, Morteza Sanei Taheri, Amir Ashraf-ganjouei, Isa Khaheshi

    Published 2019-01-01
    “…Atrial measurements are correlated with POAI, and they could be used as sensitive parameters in predicting heart failure in patients with PE.…”
    Get full text
    Article
  8. 888

    Early mortality, epidemiological and clinical factors in seriously ill patients treated in Intermediate Care Units by Osmani Pérez Ortiz, Angel Antonio Urbay Ruíz, Elaine Teresa Gutiérrez Pérez, Lis Marlyn Rodríguez García, Ivette Irene Molina Linares, Ernesto Conyedo Vergel

    Published 2024-02-01
    “…Patients with septic shock were six times more likely to die, those diagnosed with out-of-hospital bronchopneumonia five times more likely, and those with ischemic stroke, exacerbated respiratory disease, or decompensated heart failure four times more likely, respectively. Conclusions: early mortality was more frequent in individuals with white skin and age over 60 years; the emerging Intensive Care Unit as the place of origin and the history of high blood pressure, upper digestive bleeding, ischemic heart disease and diabetes mellitus predominated. …”
    Get full text
    Article
  9. 889

    Effects on Serum Fractalkine by Diet and Omega-3 Fatty Acid Intervention: Relation to Clinical Outcome by Kristian Laake, Ingebjørg Seljeflot, Morten Wang Fagerland, Ida Unhammer Njerve, Harald Arnesen, Svein Solheim

    Published 2015-01-01
    “…Increased serum levels have been reported in unstable coronary artery disease (CAD) and to predict mortality in heart failure. Mediterranean-like diet and omega-3 fatty acids (n3-PUFA) have documented cardioprotective and anti-inflammatory effects. …”
    Get full text
    Article
  10. 890

    Ranolazine Induced Bradycardia, Renal Failure, and Hyperkalemia: A BRASH Syndrome Variant by Syed Arsalan Akhter Zaidi, Danial Shaikh, Muhammad Saad, Timothy J. Vittorio

    Published 2019-01-01
    “…Her medical comorbidities included hypertension, diabetes, CAD, heart failure with preserved ejection fraction, paroxysmal atrial fibrillation, hypothyroidism, and a history of cerebrovascular accident without any residual deficits. …”
    Get full text
    Article
  11. 891

    Risk factors related to COVID-19. Turcios Lima Polyclinic. Pinar del Rio, 2020-2021 by Jorge Félix Rodríguez Ramos, Gema Chávez Ivizate, Raquel Piloto González

    Published 2023-03-01
    “…<br /><strong>Results</strong>: the most frequent risk factors were: male sex (X2=8.5900; p&lt;0.001), urban residence (X2=509.03; p&lt;0.001) and occupation as a student or worker (X2=199 .93, p&lt;0.001); as well as personal medical history of diabetes mellitus, arterial hypertension, ischemic heart disease, bronchial asthma, heart failure, and chronic obstructive pulmonary disease.…”
    Get full text
    Article
  12. 892

    The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) by Denda Nikola I., Maletin Nemanja Z., Atanasković Marko B., Vučković Biljana A., Rašković Aleksandar L.

    Published 2024-01-01
    “…Methods: A thorough review of literature from 2000 to 2023 via PubMed focused on SGLT2 inhibitors' pharmacology and clinical impact on T2DM, heart failure, and chronic kidney disease. Twenty relevant studies were analyzed to understand differences between these inhibitors, refining their efficacy and safety profiles. …”
    Get full text
    Article
  13. 893

    Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway by Hong Wei, Rui Bu, Qinghui Yang, Jing Jia, Tao Li, Qiuping Wang, Yanjun Chen

    Published 2019-01-01
    “…Diabetic cardiomyopathy is a common cardiac condition in patients with diabetes mellitus, which results in cardiac hypertrophy and subsequent heart failure. Chronic inflammation in the diabetic heart results in loss of cardiomyocytes and subsequentially cardiac dysfunction. …”
    Get full text
    Article
  14. 894

    Cardiac events and procedures following COVID-19 compared with other pneumonias: a national register study by Knut Stavem, Peder Langeland Myhre, Kristian Berge, Tarjei Øvrebotten, Birgitte Tholin

    Published 2025-02-01
    “…We defined outcomes using ICD-10 codes for incident myocarditis, acute myocardial infarction, atrial fibrillation/flutter, heart failure, ischaemic heart disease, other cardiac disease and total cardiac disease (any heart condition). …”
    Get full text
    Article
  15. 895

    Left Bundle Branch Area Pacing versus Right Ventricular Pacing in Patients with Atrioventricular Block: An Observational Cohort Study by Zhongxiu Chen, Yuanning Xu, Lingyun Jiang, Ran Zhang, Hongsen Zhao, Ran Liu, Lei Zhang, Yajiao Li, Xingbin Liu

    Published 2023-01-01
    “…The primary composite outcome included all-cause mortality, lead failure, or heart failure hospitalization (HFH). The secondary outcome included periprocedure complication, cardiac death, or recurrent unexplained syncope. …”
    Get full text
    Article
  16. 896
  17. 897

    Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents by Amir F. Mohani, Srikanth Penumetsa, Amin Daoulah, Gregory Giugliano, Amir Lotfi

    Published 2018-01-01
    “…The primary outcome compared was a composite of all-cause death, myocardial infarction (MI), congestive heart failure (CHF), target vessel revascularization (TVR), and stroke at 30 days and one year. …”
    Get full text
    Article
  18. 898

    Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses by Xiaowen Shi, Bin Zhang, Zhenliang Chu, Bingjiang Han, Xueping Zhang, Ping Huang, Jibo Han

    Published 2021-01-01
    “…Cardiac hypertrophy is one of the initial disorders of the cardiovascular system and can induce heart failure. Oxidative stress is an important pathophysiological mechanism of cardiac hypertrophy. …”
    Get full text
    Article
  19. 899

    Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation by Günseli Çubukçuoğlu Deniz, Serkan Durdu, Yeşim Doğan, Esra Erdemli, Hilal Özdağ, Ahmet Ruchan Akar

    Published 2021-01-01
    “…QRT-PCR analysis confirmed that AFib persistence was associated with increased expression molecular changes underlying a transition to heart failure (NPPB, P=0.002; ANGPTL2, P=0.002; IGFBP2, P=0.010), structural remodeling including changes in the extracellular matrix and cellular stress response (COLQ, P=0.003; COMP, P=0.028; DHRS9, P=0.038; CHGB, P=0.038), and cellular stress response (DNAJA4, P=0.038). …”
    Get full text
    Article
  20. 900

    The Relation between Pregnancy-Associated Plasma Protein A and Obstructive Sleep Apnea Syndrome by Ali Cengiz, Suat Konuk, Tuncer Tuğ

    Published 2018-01-01
    “…The participants having rheumatic or systemic inflammatory disease, advanced liver or kidney failure, diabetes, heart failure, hypertension, pregnancy, prerenal azotemia, known history of coronary artery disease, any pulmonary disease, rhinitis, or atopy, history of major trauma or surgery within the last six 6 months, and inhaled nasal or systemic corticosteroid use or other anti-inflammatory medications and those with <18 years of age were excluded. …”
    Get full text
    Article